Skip to content

DISCLAIMER: This article is a SPONSORED Press Release and does not constitute Finbold's editorial content. Crypto assets/products involve significant risks. Do not invest unless you are prepared to lose your entire investment. For a full disclaimer, please click here.

Crypto Market Enters Greed; Traders Shift Into Injective (INJ), Stacks (STX), and InQubeta (QUBE)

Crypto Market Enters Greed; Traders Shift Into Injective (INJ), Stacks (STX), and InQubeta (QUBE)
Press Releases

It has been an exciting couple of weeks in the crypto space. From Bitcoin soaring past $50,000 to Wormhole’s snapshot of eligible wallets for its upcoming airdrop to GoDaddy’s recent integration with ENS, it has been a month to remember. Hence, the market’s entry into “greed” comes as no surprise.

Following the wave of excitement, traders have been shifting into Injective (INJ), Stacks (STX), and InQubeta (QUBE), aiming to ride their bullish wave. Boasting massive growth potential, these are the best coins to invest in.

InQubeta (QUBE): Traders’ New Favorite

InQubeta (QUBE) has been stirring up quite a buzz in the crypto landscape. It recently blasted through $9.7 million in early funding, leaving early holders excited. This incredible performance has set it apart as one of the most promising new ICOs.

It further stands out thanks to its fascinating blend of AI and crypto, which are two of the most disruptive innovations in the world. As an AI altcoin, it will reshape the AI sector, meaning it will play a key role, which will usher in massive token demand. The key challenges it aims to solve are fundraising and accessibility to the market, which its crypto-based crowdfunding platform and NFT marketplace will address.

To raise much-needed capital, AI tech startups will mint investment opportunities, which will be represented as NFTs. Further, these unique non-fungible NFTs will be divided into bits, thereby allowing investors and enthusiasts to own stakes in lucrative AI businesses.

In stage 7 of the presale, a token costs just $0.0224. Meanwhile, according to analysts’ predictions, this emerging crypto will experience a 70x jump after its launch, positioning it as the best new crypto to invest in and a recommended presale.

Injective (INJ): Price Discovery

Injective (INJ) found itself in the spotlight after its explosive growth last year. It soared from $1 to breaking the $40 barrier in 2023, although it has declined a bit since then. With further room for growth in 2024, INJ is among the best cryptos to invest in, which explains traders’ keen interest.

As one of the top altcoins, and among the most promising, Injective is expected to ride this year’s bullish wave. Its performance in 2024 is set to dwarf its remarkable bull run last year; hence, there is more to look forward to.

If you don’t wish to miss this ride as it goes on price discovery and creates an all-time high (ATH), now might be one of the best times to invest in Injective. Simply accumulate some of the tokens in your portfolio to position yourself for significant gains.

Stacks (STX): Remarkable Market Performance

Stacks (STX) is among the top crypto coins on the market, and for good reasons. First, it ranks among the top 30 coins and boasts remarkable market performance and solid fundamentals. As a Bitcoin layer for smart contracts, it plays a critical role within the crypto space.

Its run last year was one of the most impressive—a 2023 highlight. Starting the new year on a strong setting, Stacks has caught investors’ attention. Given its staggering room for growth, it is among the best cryptos to buy now.

According to analysts’ forecasts, it will soar past $10 before the end of the year. If you don’t have Stacks in your portfolio, we suggest doing so to ride this bullish wave.


As the crypto market enters “greed” on the fear and greed index, eyes are on Stacks, Injective, and InQubeta. These altcoins are buzzing with potential, making them compelling investments, especially QUBE. To participate in the ongoing ICO, click the link below.

Visit InQubeta Presale 

Join The InQubeta Communities


This post is sponsored. Finbold neither endorses nor takes responsibility for the accuracy, quality, advertising, products, or other materials on this page. Readers are strongly encouraged to perform their own research before making any decisions regarding the company. Finbold will not be held accountable, either directly or indirectly, for any harm or loss that may stem from or be linked to the usage or reliance on any information, goods, or services mentioned on the page. If you encounter any issues, kindly report them to [email protected].